OTC Markets OTCPK - Delayed Quote USD
Siegfried Holding AG (SGFEF)
102.50
0.00
(0.00%)
At close: April 28 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,294,573
1,294,573
1,271,494
1,229,518
1,102,423
Cost of Revenue
965,516
965,516
951,086
910,628
862,853
Gross Profit
329,057
329,057
320,408
318,890
239,570
Operating Expense
129,797
129,797
151,741
89,913
107,582
Operating Income
199,260
199,260
168,667
228,977
131,988
Net Non Operating Interest Income Expense
-6,461
-6,461
-8,919
-7,717
-4,075
Pretax Income
196,268
196,268
150,376
218,774
126,527
Tax Provision
36,379
36,379
37,682
62,284
30,928
Net Income Common Stockholders
160,064
160,064
112,774
156,490
95,600
Diluted NI Available to Com Stockholders
160,064
160,064
112,774
156,490
95,600
Basic EPS
37.14
37.14
26.61
37.07
22.73
Diluted EPS
36.88
36.88
26.22
36.28
22.03
Basic Average Shares
4,309.44
4,309.44
4,237.79
4,221.04
4,205.43
Diluted Average Shares
4,340.61
4,340.61
4,300.31
4,313.42
4,340.09
Total Operating Income as Reported
199,260
199,260
172,068
230,777
131,953
Total Expenses
1,095,313
1,095,313
1,102,827
1,000,541
970,435
Net Income from Continuing & Discontinued Operation
160,064
160,064
112,774
156,490
95,600
Normalized Income
160,064
160,064
110,227.40
155,203
95,600
Interest Income
2,167
2,167
570
57
86
Interest Expense
8,500
8,500
9,300
7,600
3,900
Net Interest Income
-6,461
-6,461
-8,919
-7,717
-4,075
EBIT
204,768
204,768
159,676
226,374
130,427
EBITDA
289,494
289,494
241,029
308,122
213,243
Reconciled Cost of Revenue
965,516
965,516
951,086
910,628
862,853
Reconciled Depreciation
84,726
84,726
81,353
81,748
82,816
Net Income from Continuing Operation Net Minority Interest
160,064
160,064
112,774
156,490
95,600
Total Unusual Items Excluding Goodwill
--
--
3,400
1,800
--
Total Unusual Items
--
--
3,400
1,800
--
Normalized EBITDA
289,494
289,494
237,629
306,322
213,243
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
--
--
853.40
513
--
12/31/2021 - 10/6/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TEVA.VI Teva Pharmaceutical Industries Limited
13.75
+2.23%
EIIA.F Eisai Co Ltd
6.00
+0.84%
H5P.F Hikma Pharmaceuticals PLC
23.20
0.00%
SBX.BE SynBiotic SE
3.4050
+20.11%
EVT.VI Evotec SE
7.46
-0.43%
PHE.F Cipher Pharmaceuticals Inc.
8.20
-2.38%
LDZU.F Aspen Pharmacare Holdings Limited
5.60
+2.75%
I7G.F Ipsen S.A.
99.40
+0.66%
EII.F Eisai Co., Ltd.
25.06
+0.93%
21P.F Aurora Cannabis Inc. R
4.0100
-2.67%